These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6423814)

  • 21. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats.
    Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J
    Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1.
    Keyes SR; Fracasso PM; Heimbrook DC; Rockwell S; Sligar SG; Sartorelli AC
    Cancer Res; 1984 Dec; 44(12 Pt 1):5638-43. PubMed ID: 6437671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major isozymes of rat liver microsomal cytochrome P-450 involved in the N-oxidation of N-isopropyl-alpha-(2-methylazo)-p-toluamide, the azo derivative of procarbazine.
    Prough RA; Brown MI; Dannan GA; Guengerich FP
    Cancer Res; 1984 Feb; 44(2):543-8. PubMed ID: 6692359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicotine metabolism in liver microsomes from rats with acute hepatitis or cirrhosis.
    Nakajima M; Iwata K; Yamamoto T; Funae Y; Yoshida T; Kuroiwa Y
    Drug Metab Dispos; 1998 Jan; 26(1):36-41. PubMed ID: 9443850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Administration of high doses of human recombinant interleukin-2 decreases the expression of several cytochromes P-450 in the rat.
    Thal C; el Kahwaji J; Loeper J; Tinel M; Doostzadeh J; Labbe G; Leclaire J; Beaune P; Pessayre D
    J Pharmacol Exp Ther; 1994 Jan; 268(1):515-21. PubMed ID: 8301593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunochemistry of catalytic activity of cytochrome P-450-LM2 from rat liver microsomes].
    Kurchenko VP; Usanov SA; Metelintsa DI
    Biokhimiia; 1982 Sep; 47(9):1431-6. PubMed ID: 6814536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in rat.
    Hartman N; Basseches PJ; Powis G
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):11-5. PubMed ID: 6819097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo effects of the arylamine human immunodeficiency virus protease inhibitor 4R-(4alpha,5alpha,6beta, 7beta)-1-[(3-(1-imidazoylcarbamoyl)phenyl)methyl]-3-[(3-aminophenyl)m ethyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1, 3-diazepin-2-one (SD894) on rat hepatic cytochrome P450 2B and 3A.
    Grubb MF; Diamond S; Christ DD
    Drug Metab Dispos; 1997 Dec; 25(12):1424-8. PubMed ID: 9394033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of substrate binding capacity of the hepatic microsomal cytochrome P-450 in Fasciola hepatica infected rats: toxicological implications.
    Maffei Facino R; Carini M
    Farmaco Sci; 1982 Mar; 37(3):184-91. PubMed ID: 6802668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
    Berrigan MJ; Marinello AJ; Pavelic Z; Williams CJ; Struck RF; Gurtoo HL
    Cancer Res; 1982 Sep; 42(9):3688-95. PubMed ID: 6809312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reciprocal effect of cyclophosphane on the liver cytochrome P-450 and immunity system].
    Kovalev IE; Shipulina NV
    Farmakol Toksikol; 1983; 46(4):71-6. PubMed ID: 6617839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations in adriamycin efficacy by phenobarbital.
    Reich SD; Bachur NR
    Cancer Res; 1976 Oct; 36(10):3803-6. PubMed ID: 954004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adriamycin metabolism in man. Evidence from urinary metabolites.
    Takanashi S; Bachur NR
    Drug Metab Dispos; 1976; 4(1):79-87. PubMed ID: 3405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
    Benjamin RS; Riggs CE; Bachur NR
    Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.
    Gurtoo HL; Marinello AJ; Struck RF; Paul B; Dahms RP
    J Biol Chem; 1981 Nov; 256(22):11691-701. PubMed ID: 7298626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two stable Fenton oxidation products of cyclophosphamide (NSC-26271) as precursors of 4-hydroxycyclophosphamide (NSC-196562) under physiologic conditions.
    Benckhuysen C; van der Steen J; Spanjersberg EJ
    Cancer Treat Rep; 1976 Apr; 60(4):369-72. PubMed ID: 945125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iminocyclophosphamide as a chemically reactive metabolite of cyclophosphamide.
    Fenselau C; Lehman JP; Myles A; Brandt J; Yost GS; Friedman OM; Colvin OM
    Drug Metab Dispos; 1982; 10(6):636-40. PubMed ID: 6130913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytochrome P-450-mediated N-dechloroethylation of cyclophosphamide and ifosfamide in the rat.
    Ruzicka JA; Ruenitz PC
    Drug Metab Dispos; 1992; 20(5):770-2. PubMed ID: 1358584
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis of 3-hydroxycyclophosphamide and studies related to its possible role in the metabolism of cyclophosphamide.
    Brandt JA; Ludeman SM; Zon G; Todhunter JA; Egan W; Dickerson R
    J Med Chem; 1981 Dec; 24(12):1404-8. PubMed ID: 7310817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.